000 04021nam a2200433 c 4500
999 _c117996
_d117996
001 117996
003 ES-MaUEC
005 20230102113838.0
006 a||||fo|||| 00| 0
007 cr nn nnnaamaa
008 191022s2019 gw a o |||| 0|eng d
020 _a9783030219161
024 7 _a10.1007/978-3-030-21916-1
_2doi
040 _aES-MaUEC
_bspa
_cES-MaUEC
_dES-MaUEC
050 4 _aRC840.H38
_bH455 2019
245 0 0 _aHelicobacter pylori in Human Diseases
_bAdvances in Microbiology, Infectious Diseases and Public Health Volume 11
_cedited by Shigeru Kamiya, Steffen Backert.
250 _aFirst edition
264 1 _aCham, Switzerland
_bSpringer International Publishing
_c2019
300 _a1 recurso en línea (XIX, 284 páginas)
_b60 ilustraciones, 20 ilustraciones a color
336 _2rdacontent
_aTexto
_btxt
337 _2rdamedia
_aelectrónico
_bc
338 _2rdacarrier
_arecurso electrónico
_bcr
347 _atext file
_bPDF
490 0 _aAdvances in Microbiology Infectious Diseases and Public Health
_x2365-2675
_v1149
490 0 _aBiomedical and Life Sciences (Springer-11642)
505 0 _aFrom the contents: 1. Genomic diversity of Helicobacter pylori and human migrations -- 2. Epidemiology, diagnosis and risk factors of Helicobacter pylori infections -- 3. Activities and functional importance of Helicobacter pylori virulence factors -- 4. Structural and functional aspects of the Helicobacter pylori proteome -- 5. Role of adhesion to epithelial cells in gastric colonization by H. pylori -- 6. Interplay of Helicobacter pylori with immune cells: impact on gastric pathology -- 7. Helicobacter pylori infection of children -- 8. Non-malignant Helicobacter pylori-associated diseases -- 9. Malignant Helicobacter pylori-associated diseases: gastric cancer and MALT lymphoma -- 10. Host genetic polymorphisms in gastric disease outcome -- 11. Helicobacter pylori genetic polymorphisms in gastric disease development -- 12. Crosstalk of Helicobacter pylori with the gastrointestinal microbiota -- 13. Treatment of Helicobacter pylori infection -- 14. Role of probiotics in eradication therapy for Helicobacter pylori infection -- 15. Immunity and vaccine development against Helicobacter pylori.
520 3 _aThis book gathers a wealth of contributions on the virulence factors and pathogenic mechanism of Helicobacter pylori, prepared by leading international experts. In addition, it explores the epidemiology, diagnosis, treatment with drugs and probiotics, and prophylaxis by vaccination, reflecting the latest advances. H. pylori is a Gram negative microaerophilic bacterium that can produce various gastric diseases including gastritis, gastroduodenal ulceration, gastric cancer and gastric MALT lymphoma. Although efforts to combat H. pylori using a combination of proton pump inhibitor and several antimicrobial drugs have significantly decreased the burden of these gastric diseases, the microbial epidemiology and gastric pathogenesis following H. pylori infection are still not fully understood. Given its scope, the book offers a valuable resource not only for basic microbiologists, but also for researchers in the fields of pathology, biochemistry and genomics, as well as medical students/scientists. .
988 _aPrimersemestre_2020_BiomedLife
650 7 _2embne
_9150368
_aInfecciones por Helicobacter pylori
700 1 _aKamiya, Shigeru
_eeditor literario
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
700 1 _aBackert, Steffen
_eeditor literario
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
_999785
710 2 _aSpringerLink (Online service)
_9106996
773 0 _tSpringer eBooks
776 0 8 _iPrinted edition:
_z9783030219154
776 0 8 _iPrinted edition:
_z9783030219178
776 0 8 _iPrinted edition:
_z9783030219185
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-030-21916-1
_zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942 _2lcc
_cLE
_n0